Stockholders' Equity (Narrative) (Details) - USD ($)			9 Months Ended
	Mar. 25, 2025	Oct. 21, 2022	Sep. 30, 2025	Sep. 30, 2024	May 13, 2025	May 12, 2025	Dec. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Net proceeds from sale of common stock on at-the market (''ATM'') program			$ 7,316,230	$ 7,673,146
Proceeds from exercise of warrants			$ 2,960,157	0
2022 Stock Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-based compensation arrangement by Share based payment award, number of shares authorized					10,750,000	6,250,000
Common stock available for future grants			4,570,042
ATM Program [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Maximum proceeds from sale of common stock on at-the market ("ATM") program		$ 50,000,000
Net proceeds from sale of common stock on at-the market (''ATM'') program	$ 35,100,000		$ 7,100,000	$ 7,700,000
Number of common shares issued (Shares)	12,400,000		2,548,713	3,433,057
Issued price per share	$ 2.83
Stock issuance costs	$ 2,400,000
Stock issuance costs paid			$ 400,000	$ 500,000
Common stock issued for exercise of warrants (in shares)			274,456
Warrants exercised during period, exercise price			140,500
Proceeds from exercise of warrants			$ 700,000
Warrants [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of warrants outstanding			6,179,840				7,602,993
Warrants exercised			1,423,153
Class of warrant, outstanding remaining life			5 months 12 days
Exercise price of warrants			$ 2.08